Home » Investors » Committee Composition

Committee Composition

by | Nov 20, 2019

Audit and Finance Committee

Compensation Committee

Nominating and Corporate Governance Committee

Thomas R. Mika

Christopher Fashek

Michael Ferguson

Martin Goldstein, M.D.

= Member
= Chairperson

Investor Contact Information

Company

Synaptogenix, Inc.
1185 Avenue of the Americas,
3rd Floor
New York, NY 10036
(973) 242-0005

Investor Relations

IR Contact
T: 800-811-5591
ir@synaptogen.com